Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

Millions of "long COVID" patients coping with debilitating "brain fog" and chronic fatigue, who are looking for answers to ...

Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, ...

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

University of Virginia researchers uncover immune system changes linked to lung damage in Long COVID patients, offering hope for personalized treatments to address lingering respiratory complications.

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the case with the creation of a treatment for Long COVID.

A new study that is the first to compare inflammation and brain stress responses in long COVID-19 patients with individuals ...